Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucle

Frey, Kathleen M.; Bertoletti, Nicole; Chan, Albert H.; Ippolito, Joseph A.; Bollini, Mariela; Spasov, Krasimir A.; Jorgensen, William L.; Anderson, Karen S.

doi:10.3389/fmolb.2022.805187

Title: Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucle

Journal Article · 01 February 2022 · Front. Mol. Biosci.

DOI:https://doi.org/10.3389/fmolb.2022.805187· OSTI ID:1863069

Frey, Kathleen M.; Bertoletti, Nicole; Chan, Albert H.; Ippolito, Joseph A.; Bollini, Mariela; Spasov, Krasimir A.; Jorgensen, William L.; Anderson, Karen S.

Cite

Export

Save

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH)

OSTI ID:: 1863069

Journal Information:: Front. Mol. Biosci., Vol. 9

Country of Publication:: United States

Language:: ENGLISH

References (38)

PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine Balamane, Maya; Varghese, Vici; Melikian, George L. Antimicrobial Agents and Chemotherapy, Vol. 56, Issue 8 https://doi.org/10.1128/AAC.00648-12	journal	August 2012
Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine Bertoletti, Nicole; Chan, Albert H.; Schinazi, Raymond F. Protein Science https://doi.org/10.1002/pro.3681	journal	August 2019
Computationally-Guided Optimization of a Docking Hit to Yield Catechol Diethers as Potent Anti-HIV Agents Bollini, Mariela; Domaoal, Robert A.; Thakur, Vinay V. Journal of Medicinal Chemistry, Vol. 54, Issue 24 https://doi.org/10.1021/jm201134m	journal	December 2011
Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility Bollini, Mariela; Cisneros, José A.; Spasov, Krasimir A. Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18 https://doi.org/10.1016/j.bmcl.2013.06.091	journal	September 2013
Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubility Bollini, Mariela; Frey, Kathleen M.; Cisneros, José A. Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18 https://doi.org/10.1016/j.bmcl.2013.06.093	journal	September 2013
Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography Chan, Albert H.; Lee, Won-Gil; Spasov, Krasimir A. Proceedings of the National Academy of Sciences, Vol. 114, Issue 36 https://doi.org/10.1073/pnas.1711463114	journal	August 2017
MolProbity : all-atom structure validation for macromolecular crystallography Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042073	journal	December 2009
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations Das, K.; Bauman, J. D.; Clark, A. D. Proceedings of the National Academy of Sciences, Vol. 105, Issue 5 https://doi.org/10.1073/pnas.0711209105	journal	January 2008
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009) de Béthune, Marie-Pierre Antiviral Research, Vol. 85, Issue 1 https://doi.org/10.1016/j.antiviral.2009.09.008	journal	January 2010
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection1Presented at the Eleventh International Conference on Antiviral Research, San Diego, CA, 5–10 April 1998.1 De Clercq, Erik Antiviral Research, Vol. 38, Issue 3 https://doi.org/10.1016/s0166-3542(98)00025-4	journal	June 1998
Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective De Clercq, Erik Journal of Medicinal Chemistry, Vol. 53, Issue 4 https://doi.org/10.1021/jm900932g	journal	October 2009
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design Frey, Kathleen M.; Bollini, Mariela; Mislak, Andrea C. Journal of the American Chemical Society, Vol. 134, Issue 48 https://doi.org/10.1021/ja3092642	journal	November 2012
Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants Frey, Kathleen M.; Puleo, David E.; Spasov, Krasimir A. Journal of Medicinal Chemistry, Vol. 58, Issue 6 https://doi.org/10.1021/jm501908a	journal	February 2015
The HIV therapy market Gubernick, Steven I.; Félix, Nuno; Lee, Dolim Nature Reviews Drug Discovery, Vol. 15, Issue 7 https://doi.org/10.1038/nrd.2016.69	journal	June 2016
Investigation of the stereochemical course of DNA synthesis catalysed by human immunodeficiency virus type 1 reverse transcriptase Hopkins, Sam; Furman, Phillip A.; Painter, George R. Biochemical and Biophysical Research Communications, Vol. 163, Issue 1 https://doi.org/10.1016/0006-291x(89)92105-0	journal	August 1989
Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead Ippolito, Joseph A.; Niu, Haichan; Bertoletti, Nicole ACS Medicinal Chemistry Letters, Vol. 12, Issue 2 https://doi.org/10.1021/acsmedchemlett.0c00612	journal	January 2021
Current Perspectives on HIV-1 Antiretroviral Drug Resistance Iyidogan, Pinar; Anderson, Karen Viruses, Vol. 6, Issue 10 https://doi.org/10.3390/v6104095	journal	October 2014
In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1 E )-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine) Janssen, Paul A. J.; Lewi, Paul J.; Arnold, Eddy Journal of Medicinal Chemistry, Vol. 48, Issue 6 https://doi.org/10.1021/jm040840e	journal	March 2005
Efficient Discovery of Potent Anti-HIV Agents Targeting the Tyr181Cys Variant of HIV Reverse Transcriptase Jorgensen, William L.; Bollini, Mariela; Thakur, Vinay V. Journal of the American Chemical Society, Vol. 133, Issue 39 https://doi.org/10.1021/ja2058583	journal	October 2011
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor Kohlstaedt, L.; Wang, J.; Friedman, J. Science, Vol. 256, Issue 5065 https://doi.org/10.1126/science.1377403	journal	June 1992
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection Kudalkar, Shalley N.; Beloor, Jagadish; Chan, Albert H. Molecular Pharmacology, Vol. 91, Issue 4 https://doi.org/10.1124/mol.116.107755	journal	February 2017
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection Kudalkar, Shalley N.; Beloor, Jagadish; Quijano, Elias Proceedings of the National Academy of Sciences, Vol. 115, Issue 4 https://doi.org/10.1073/pnas.1717932115	journal	December 2017
Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design Lansdon, Eric B.; Brendza, Katherine M.; Hung, Magdeleine Journal of Medicinal Chemistry, Vol. 53, Issue 10 https://doi.org/10.1021/jm1002233	journal	May 2010
Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group Lee, Won-Gil; Gallardo-Macias, Ricardo; Frey, Kathleen M. Journal of the American Chemical Society, Vol. 135, Issue 44 https://doi.org/10.1021/ja408917n	journal	October 2013
Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers Lee, Won-Gil; Frey, Kathleen M.; Gallardo-Macias, Ricardo ACS Medicinal Chemistry Letters, Vol. 5, Issue 11 https://doi.org/10.1021/ml5003713	journal	September 2014
Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase Lee, Won-Gil; Frey, Kathleen M.; Gallardo-Macias, Ricardo Bioorganic & Medicinal Chemistry Letters, Vol. 25, Issue 21 https://doi.org/10.1016/j.bmcl.2015.06.074	journal	November 2015
Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development Martin, Elizabeth Anne; Lai, Ming-Tain; Ngo, Winnie JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 85, Issue 5 https://doi.org/10.1097/QAI.0000000000002496	journal	January 2020
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8 https://doi.org/10.1107/S0907444906019949	journal	July 2006
Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT Nissley, Dwight V.; Radzio, Jessica; Ambrose, Zandrea Biochemical Journal, Vol. 404, Issue 1 https://doi.org/10.1042/bj20061814	journal	April 2007
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later Pannecouque, Christophe; Daelemans, Dirk; De Clercq, Erik Nature Protocols, Vol. 3, Issue 3 https://doi.org/10.1038/nprot.2007.517	journal	February 2008
The Challenge of Finding a Cure for HIV Infection Richman, D. D.; Margolis, D. M.; Delaney, M. Science, Vol. 323, Issue 5919 https://doi.org/10.1126/science.1165706	journal	March 2009
Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Rittinger, K.; Divita, G.; Goody, R. S. Proceedings of the National Academy of Sciences, Vol. 92, Issue 17 https://doi.org/10.1073/pnas.92.17.8046	journal	August 1995
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Rodgers, D. W.; Gamblin, S. J.; Harris, B. A. Proceedings of the National Academy of Sciences, Vol. 92, Issue 4 https://doi.org/10.1073/pnas.92.4.1222	journal	February 1995
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors Spence, R.; Kati, W.; Anderson, K. Science, Vol. 267, Issue 5200 https://doi.org/10.1126/science.7532321	journal	February 1995
Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias Terwilliger, Thomas C.; Grosse-Kunstleve, Ralf W.; Afonine, Pavel V. Acta Crystallographica Section D Biological Crystallography, Vol. 64, Issue 5 https://doi.org/10.1107/S0907444908004319	journal	April 2008

Similar Records

Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucle

Journal Article · 2022 · Front. Mol. Biosci. · OSTI ID:1863069

Frey, Kathleen M.; Bertoletti, Nicole; Chan, Albert H.; +5 more

Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection

Journal Article · 2017 · Molecular Pharmacology · OSTI ID:1863069

Kudalkar, Shalley N.; Beloor, Jagadish; Chan, Albert H.; +4 more

Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3′,2′:3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2′,3′:4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5′-monophosphate-activated protein kinase (AMPK)

Journal Article · 2018 · Bioorganic and Medicinal Chemistry · OSTI ID:1863069

Gu, Zhanni; Wu, Lingyan; Duan, Yanan; +6 more

Title: Structural Studies and Structure Activity Relationships for Novel Computationally Designed Non-nucle

Citation Formats

References (38)

Similar Records

Related Subjects